دورية أكاديمية
LBA2 Impact of RNA expression signatures and tumour infiltrating lymphocytes (TILs) for pathological complete response (pCR) and survival after 12 week de-escalated neoadjuvant pertuzumab + trastuzumab ± paclitaxel in the WSG-HER2+/HR- ADAPT trial
| العنوان: | LBA2 Impact of RNA expression signatures and tumour infiltrating lymphocytes (TILs) for pathological complete response (pCR) and survival after 12 week de-escalated neoadjuvant pertuzumab + trastuzumab ± paclitaxel in the WSG-HER2+/HR- ADAPT trial |
|---|---|
| المؤلفون: | Graeser, M., Gluz, O., Biehl, C., Ulbrich-Gebauer, D., Palatty, J., Christgen, M., Kuemmel, S., Grischke, E-M., Augustin, D., Braun, M., Potenberg, J., Wuerstlein, R., Eulenburg, C., Kates, R., Kolberg-Liedtke, C., Feuerhake, F., Kreipe, H., Nitz, U., Harbeck, N. |
| المصدر: | Annals of Oncology ; volume 32, page S48 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2021 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2021.03.215 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2021.03.215Test https://api.elsevier.com/content/article/PII:S0923753421011443?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753421011443?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.5C4C0E1D |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2021.03.215 |
|---|